Glp-1s cover a variety of drugs that are commonly used for weight loss, such as Ozempic, Wegovy and Mounjaro. And West Virginians used them at the highest rate ...

Eli Lilly is one of the top growth stocks in the pharmaceutical industry. Vertex Pharmaceuticals boasts multiple growth ...

On Thursday, Jim Cramer, the host of Mad Money, discussed the recent turbulence in the stock market, pointing to the lack of ...

Stanford researchers have discovered BRP, a naturally occurring peptide that suppresses appetite and promotes weight loss, ...

Beyond type 2 diabetes and weight loss, GLP-1 agonists can also help lower blood pressure, improve lipid disorders, reduce ...

On February 21, 2025, the US Food and Drug Administration (FDA) revised its shortage categorization of semaglutide, a glucagon-like peptide 1 ...

Less than a year after cutting coverage of GLP-1 weight loss drugs such as Wegovy, the North Carolina State Health Plan is now asking the legislature to pay for bringing back coverage.

Indianapolis-based Eli Lilly and Co. launched LillyDirect a little more than a year ago and has been ramping up efforts to ...

Impressions Face + Body owner says he's noticed a spike in interest from clients hoping to get face and body-lifts offered ...

With semaglutide shortages in the rearview, Novo Nordisk is doubling down on marketing efforts for its GLP-1 drugs.

Register today to learn how to build an effective, sustainable GLP-1 strategy that benefits everyone on your health plan.

Shares of Hims & Hers Health ( HIMS) tumbled 15% yesterday after Novo Nordisk (NVO) announced it was cutting the price of its ...